DNA Methylation of the ABO Promoter Underlies Loss of ABO Allelic Expression in a Significant Proportion of Leukemic Patients
Open Access
- 10 March 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (3), e4788
- https://doi.org/10.1371/journal.pone.0004788
Abstract
Loss of A, B and H antigens from the red blood cells of patients with myeloid malignancies is a frequent occurrence. Previously, we have reported alterations in ABH antigens on the red blood cells of 55% of patients with myeloid malignancies. To determine the underlying molecular mechanisms of this loss, we assessed ABO allelic expression in 21 patients with ABH antigen loss previously identified by flow cytometric analysis as well as an additional 7 patients detected with ABH antigen changes by serology. When assessing ABO mRNA allelic expression, 6/12 (50%) patients with ABH antigen loss detected by flow cytometry and 5/7 (71%) of the patients with ABH antigen loss detected by serology had a corresponding ABO mRNA allelic loss of expression. We examined the ABO locus for copy number and DNA methylation alterations in 21 patients, 11 with loss of expression of one or both ABO alleles, and 10 patients with no detectable allelic loss of ABO mRNA expression. No loss of heterozygosity (LOH) at the ABO locus was observed in these patients. However in 8/11 (73%) patients with loss of ABO allelic expression, the ABO promoter was methylated compared with 2/10 (20%) of patients with no ABO allelic expression loss (P = 0.03). We have found that loss of ABH antigens in patients with hematological malignancies is associated with a corresponding loss of ABO allelic expression in a significant proportion of patients. Loss of ABO allelic expression was strongly associated with DNA methylation of the ABO promoter.This publication has 59 references indexed in Scilit:
- Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylationNucleic Acids Research, 2007
- The Prognostic Impact of Blood Group-Related Antigen Lewis Y and the ABH Blood Groups in Resected Non-Small Cell Lung CancerTumor Biology, 2007
- Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome bandNature Genetics, 2006
- Localization of the human growth arrest-specific gene (GAS1) to chromosome bands 9q21.3-q22, a region frequently deleted in myeloid malignanciesGenomics, 1993
- Expression of Blood-Group Antigen A — A Favorable Prognostic Factor in Non-Small-Cell Lung CancerNew England Journal of Medicine, 1991
- Cloning the ABH genesTransfusion, 1990
- Clonal Chromosomal Abnormalities Showing Multiple-Cell-Lineage Involvement in Acute Myeloid LeukemiaNew England Journal of Medicine, 1988
- Level of the A, B and H blood group glycosyltransferases in red cell membranes from patients with malignant hemopathiesRevue Française de Transfusion et Immuno-hématologie, 1984
- DIFFERENCES IN THE TWO RED-CELL POPULATIONS IN ERYTHROLEUKÆMIAThe Lancet, 1971
- Two A Antigens with Abnormal Serologic PropertiesVox Sanguinis, 1957